Baxter Healthcare 250mL IV Bag Recall: Leaking Bags Risk Infection
Baxter Healthcare recalls 250mL 0.9% Sodium Chloride Injection bags due to leaking containers that could cause infection. Affected units were distributed in Canada with specific product codes.
Use caution until it’s fixed
Lack of Assurance of Sterility: Customer complaints for leaking bags.
Contact the company
What happened, in plain English
Baxter Healthcare is recalling 250mL 0.9% Sodium Chloride Injection bags because customer complaints indicate leaking bags. This could lead to infection risks if the bags are used for medical purposes. Read more at govinfonow.com/recall/41511-baxter-healthcare-250ml-iv-bag-recall-leaking-bags-risk-infection.
Source Summary by GovInfoNow · govinfonow.com/recall/41511-baxter-healthcare-250ml-iv-bag-recall-leaking-bags-risk-infection · Updated October 8, 2026 · FDA enforcement record: FDA #D-0957-2017
Cite this page
“Baxter Healthcare 250mL IV Bag Recall: Leaking Bags Risk Infection.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41511-baxter-healthcare-250ml-iv-bag-recall-leaking-bags-risk-infection. Based on FDA recall #D-0957-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0957-2017%22&limit=1).
Why it’s dangerous
Leaking bags can contaminate the IV solution, potentially causing infections in patients. The lack of sterility means the solution may not be safe for medical use.
Who’s affected
Healthcare providers and patients using this IV bag for medical treatments. Those with the specific product code or lot number are most at risk.
How to tell if you have this one
Check for the product code 2B1322, NDC 0338-0049-02, or lot number Y229153. The bags were distributed in Canada and sold with the specific product details.
- Brand
Baxter Healthcare- Category
Drug
What to do — step by step
Check for Leaks
Inspect the bag for signs of leakage, as leaking bags can cause contamination.
Contact Healthcare Provider
Reach out to your healthcare provider for guidance on safe handling or alternative solutions.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Baxter Healthcare recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0957-2017 (July 6, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0957-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.